Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Impaired Glucose Tolerance: full-pipeline trial registry
4 of 14 indexed Impaired Glucose Tolerance trials are currently recruiting.
Corpus placement: #1,230 of 28,707 conditions by registered trial count.
14 US clinical trials · 4 currently recruiting · #1,230 of 28,707 conditions by registered trial count
Impaired Glucose Tolerance: 14 US clinical trials tracked, 4 recruiting.
Impaired Glucose Tolerance is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Unicity International, running 1 of these trials.
Enrollment posture brief
Registry condition impaired-glucose-tolerance
OPEN 4 | RECR 29% | LATE 2 | EARLY 3 | RANK #1230 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acne Scars (29% recruiting · 7 trials)
Impaired Glucose Tolerance lists 4 open slots (29% of 14 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Impaired Glucose Tolerance on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Impaired Glucose Tolerance is recruiting below its size-band peers.
4 of 14 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Impaired Glucose Tolerance trials is spread across many organizations.
Unicity International accounts for 1 of 14 trials (7.1%). 14 distinct sponsors appear on at least one study for this condition label.
-
Most Impaired Glucose Tolerance trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 14 trials that report a genuine target (sentinel values excluded). 11 of those (78.6%) plan for fewer than 100 participants.
-
Impaired Glucose Tolerance research is mostly interventional.
14 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
14 total, page 1 of 1
Night Owl Metabolism
Johns Hopkins University
NCT06507722
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
Yale University
NCT05067621
The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults
University of New Hampshire
NCT05912348
CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance
Nemours Children's Clinic
NCT05387551
The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans
Ohio State University
NCT03938389
Improving Autonomic Function and Balance in Diabetic Neuropathy
VA Office of Research and Development
NCT01864460
To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies
Novartis
NCT01068860
D Vitamin Intervention in VA
US Department of Veterans Affairs
NCT01375660
The Effect of Real Time Continuous Glucose Monitoring in Subjects With Pre-diabetes
Walter Reed National Military Medical Center
NCT01741467
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT01030861
Effect of Dietary Glycemic Index on Beta-cell Function
Seattle Institute for Biomedical and Clinical Research
NCT01386645
Effects of an Intermittent Fasting and Dietary Supplement Regimen on Glycemic Variability
Unicity International
NCT05493553
The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
Beth Israel Deaconess Medical Center
NCT00456885
Sucralose, Stevia, Gut Microbiome and Glucose Metabolism
University of Minnesota
NCT02800707
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Impaired Glucose Tolerance records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Impaired Glucose Tolerance trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Impaired Glucose Tolerance page
14 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Impaired Glucose Tolerance trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Unicity International sponsors the most Impaired Glucose Tolerance trials on record, review their full trial history before evaluating a specific study. See Unicity International's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Impaired Glucose Tolerance condition card totals 14 registered trials; most-linked intervention Placebo; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.